HAS2 and neoplasm: CD44s additionally promoted the expression of hyaluronan synthase 2 (HAS2) by activating the PI3K/AKT signalling pathway, which further enhanced CD44s-mediated PI3K/AKT signalling, thus creating a positive feedback loop to drive tumour cell survival in breast cancer cells [125].